Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, posted on X:
“Innovation trial. Can additon of trastuzumab With or without Pertuzumab into perioperative chemo makes a difference in OS for her2 postive stomach cancer. Answer is NO. Negative trial. May be her2 is not a strong driver pathway in stomach as it is in breast.”
